STE STERIS plc

  1. Stocks
  2. Healthcare
  3. NYSE: STE

Price (delayed)

$192.69

Market cap

$16.44B

P/E Ratio

38.69

Dividend/share

$1.54

EPS

$4.98

Enterprise value

$17.29B

Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: https://www.steris.com/

Steris Corporation is an American Irish-domiciled medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, but has been ...

Highlights

The company's net income rose by 26% YoY and by 2.7% QoQ
The company's EPS rose by 25% YoY and by 2.5% QoQ
STE's P/E is 20% above its last 4 quarters average of 32.2

Key stats

What are the main financial stats of STE
Market
Shares outstanding
85.32M
Market cap
$16.44B
Enterprise value
$17.29B
Valuations
Price to earnings (P/E)
38.69
Price to book (P/B)
4.49
Price to sales (P/S)
5.42
EV/EBIT
30.86
EV/EBITDA
22.63
EV/Sales
5.72
Earnings
Revenue
$3.02B
EBIT
$560.37M
EBITDA
$764.24M
Free cash flow
$403.76M
Per share
EPS
$4.98
Free cash flow per share
$4.75
Book value per share
$42.88
Revenue per share
$35.53
TBVPS
$29.68
Balance sheet
Total assets
$5.49B
Total liabilities
$1.83B
Debt
$1.17B
Equity
$3.65B
Working capital
$714.89M
Liquidity
Debt to equity
0.32
Current ratio
2.64
Quick ratio
1.87
Net debt/EBITDA
1.12
Margins
EBITDA margin
25.3%
Gross margin
43.4%
Net margin
14%
Operating margin
18.4%
Efficiency
Return on assets
7.8%
Return on equity
12.2%
Return on invested capital
19.1%
Return on capital employed
11.1%
Return on sales
18.5%
Dividend
Dividend yield
0.8%
DPS
$1.54
Payout ratio
30.9%

STE stock price

How has the STERIS stock price performed over time
Intraday
-0.06%
1 week
1.8%
1 month
9.25%
1 year
26.7%
YTD
26.42%
QTD
9.36%

Financial performance

How have STERIS's revenue and profit performed over time
Revenue
$3.02B
Gross profit
$1.31B
Operating income
$555.42M
Net income
$422.29M
Gross margin
43.4%
Net margin
14%
The company's net income rose by 26% YoY and by 2.7% QoQ
STE's operating income is up by 24% YoY and by 2.7% from the previous quarter
STERIS's net margin has increased by 21% YoY and by 2.2% from the previous quarter
STE's operating margin is up by 19% year-on-year and by 2.2% since the previous quarter

Growth

What is STERIS's growth rate over time

Valuation

What is STERIS stock price valuation
P/E
38.69
P/B
4.49
P/S
5.42
EV/EBIT
30.86
EV/EBITDA
22.63
EV/Sales
5.72
The company's EPS rose by 25% YoY and by 2.5% QoQ
STE's P/E is 20% above its last 4 quarters average of 32.2
STE's P/B is 55% above its 5-year quarterly average of 2.9 and 18% above its last 4 quarters average of 3.8
The company's equity rose by 13% YoY and by 5% QoQ
The P/S is 59% above the 5-year quarterly average of 3.4 and 23% above the last 4 quarters average of 4.4
The revenue has grown by 4.3% YoY

Efficiency

How efficient is STERIS business performance
STERIS's ROIC has increased by 19% YoY and by 3.2% from the previous quarter
The company's return on sales rose by 19% YoY
STERIS's ROA has increased by 18% YoY
The ROE has increased by 16% YoY

Dividends

What is STE's dividend history
DPS
$1.54
Dividend yield
0.8%
Payout ratio
30.9%
Recent dividends

Financial health

How did STERIS financials performed over time
STERIS's quick ratio has increased by 18% from the previous quarter and by 8% YoY
STERIS's current ratio has increased by 15% QoQ and by 10% YoY
STERIS's debt is 68% less than its equity
STE's debt to equity is down by 20% year-on-year and by 9% since the previous quarter
The company's equity rose by 13% YoY and by 5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.